Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, ...
TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an oncology company integrating novel delivery technology with standard of care therapies, and its investigational immunotherapeutic to ...
Zura Bio Limited (Nasdaq: ZURA) (“Zura” or the “Company”), a clinical‑stage biotechnology company developing novel and ...
FILSPARI achieved record 993 new PSFs for IgAN in the U.S. in the first quarter; U.S. net product sales grew 88% year over ...
KELOWNA, BC / ACCESS Newswire / May 4, 2026 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU) ("Avant" or the "Company"), is pleased to announce the voting results from its annual general and ...
UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today reported net income of $17.5 ...
Symposia leadership and multiple accepted abstracts position intact fish skin at the forefront of evidence-based wound ...
New Partnership Expands Pharmacists Mutual's Professional Liability Capabilities in Healthcare Market ALGONA, IA / ACCESS Newswire / May 4, 2026 / Pharmacists Mutual Insurance Group ("Pharmacists ...
CLERMONT-FERRAND, France & TOKYO, Japan--(BUSINESS WIRE)--#innovation--Kubota Vision Inc. (“Kubota Vision”), a wholly-owned ...
Investigational TAK-881 was comparable to established HYQVIA while also demonstrating reduced infusion volume and duration for PID patientsOSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE ...
Surveyed HCPs identified reduction of days on TPN as a top priority –– Improved quality of life, lower risk of infection and thrombosis viewed as key benefits of reduced TPN dependence –– Additional ...
New Gibco™ CTS™ DynaXS™ Single Use Bioreactor supports flexible, cGMP-ready cell expansion from process development to clinical production to support the development of cell therapies for cancer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results